Cerdulatinib (PRT062070) hydrochloride

Cerdulatinib (PRT-062070, PRT2070) hydrochloride is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively. Also inhibits 19 other tested kinases with IC50 less than 200 nM.

Price Not Available 200mg Cerdulatinib (PRT062070) hydrochloride Supplier Page

Trivial name	PRT2070 hydrochloride
Catalog Number	S7634
Molecular Formula	C20H28ClN7O3S
CAS#	1369761-01-2
Inchi	InChI=1S/C20H27N7O3S.ClH/c1-2-31(29,30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14;/h5-8,13-14H,2-4,9-12H2,1H3,(H2,21,28)(H2,22,23,24,25);1H
Inchi Key	IYULGYKOHUAYCG-UHFFFAOYSA-N
SMILES	CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N.Cl
Size	200mg
Supplier Page	http://www.selleckchem.com/products/cerdulatinib-prt062070-prt2070.html
Additional Information	https://file.selleck.cn/downloads/struct/cerdulatinib-prt-062070-chemical-structure-s7634.gif